Monday, October 22, 2012

5-question survey may increase COPD diagnoses

5-question survey may increase COPD diagnoses [ Back to EurekAlert! ] Public release date: 22-Oct-2012
[ | E-mail | Share Share ]

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians

A simple, five-question patient-administered survey (COPD-PS) may lead to increased diagnoses of chronic obstructive pulmonary disease (COPD). Researchers from David Geffen School of Medicine at UCLA, Olmsted Medical Center, Boehringer-Ingelheim Pharmaceuticals Inc , and Pfizer Inc, randomized 9,704 patients with no prior COPD diagnosis from US primary care practices in seven states into three groups based on treatment: Arm 1: COPD-PS plus spirometry; Arm 2: COPD-PS alone; Arm 3: usual care. Results showed that the rate of new COPD diagnoses within 8 weeks of visit 1 was statistically significantly higher in Arms 1 and 2 than Arm 3, with the highest yield seen in Arm 1, the combination screening group. Researchers conclude that screening tools in primary care could facilitate diagnosis of COPD in primary care. This study was presented during CHEST 2012, the annual meeting of the American College of Chest Physicians, held October 20 25, in Atlanta, Georgia.

###


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


5-question survey may increase COPD diagnoses [ Back to EurekAlert! ] Public release date: 22-Oct-2012
[ | E-mail | Share Share ]

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians

A simple, five-question patient-administered survey (COPD-PS) may lead to increased diagnoses of chronic obstructive pulmonary disease (COPD). Researchers from David Geffen School of Medicine at UCLA, Olmsted Medical Center, Boehringer-Ingelheim Pharmaceuticals Inc , and Pfizer Inc, randomized 9,704 patients with no prior COPD diagnosis from US primary care practices in seven states into three groups based on treatment: Arm 1: COPD-PS plus spirometry; Arm 2: COPD-PS alone; Arm 3: usual care. Results showed that the rate of new COPD diagnoses within 8 weeks of visit 1 was statistically significantly higher in Arms 1 and 2 than Arm 3, with the highest yield seen in Arm 1, the combination screening group. Researchers conclude that screening tools in primary care could facilitate diagnosis of COPD in primary care. This study was presented during CHEST 2012, the annual meeting of the American College of Chest Physicians, held October 20 25, in Atlanta, Georgia.

###


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2012-10/acoc-fsm101712.php

mr rogers jamie lee curtis spring equinox audacious pollen count mexico city first day of spring

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.